跳至主要内容
临床试验/CTRI/2012/12/003270
CTRI/2012/12/003270招募中3 期

Aqueous vascular endothelial growth factor (VEGF) profile in central retinal vein occlusion (CRVO) and its correlation with clinical features, spectral domain optical coherence tomography(SD OCT), electroretinogram (ERG) and macular integrity assessment (MAIA) - ProCRVO

arayana Nethralaya0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion Criteria
  • Patients with central retinal vein occlusion who are treatment naïve with or without visual loss < 3 months duration with or without glaucoma
  • Patients with well controlled DM will be included when the other eye has less than severe non proliferative diabetic retinopathy

排除标准

  • Exclusion Criteria
  • Ocular intervention within 3 months like intra ocular surgery, intravitreal steroid/anti VEGF injections and previous history of retinal laser treatment.
  • Neovascular glaucoma
  • IOP > 21 mmHg
  • Ocular inflammatory conditions
  • Age related macular degeneration

研究者

发起方
arayana Nethralaya

相似试验

A clinical trial to study the levels of vascular... | 临床试验